Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors

BACKGROUND: Pancreatic ductal adenocarcinoma is a particularly challenging malignancy characterized by poor responsiveness to conventional chemotherapy. Although this tumor frequently overexpresses or possesses constitutively activated variants of IGF-IR and EGFR/Her-2, clinical trials using inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Urtasun, Nerea, Vidal-Pla, Anna, Pérez-Torras, Sandra, Mazo, Adela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403908/
https://www.ncbi.nlm.nih.gov/pubmed/25886138
http://dx.doi.org/10.1186/s12885-015-1249-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403908/
https://www.ncbi.nlm.nih.gov/pubmed/25886138
http://dx.doi.org/10.1186/s12885-015-1249-2

Ejemplares similares